Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Holdings Revenue

Xeris Biopharma Holdings had revenue of $60.12M in the quarter ending March 31, 2025, with 47.94% growth. This brings the company's revenue in the last twelve months to $222.55M, up 29.88% year-over-year. In the year 2024, Xeris Biopharma Holdings had annual revenue of $203.07M with 23.89% growth.

• Revenue (ttm): $222.55M
• Revenue Growth: +29.88%
• P/S Ratio: 3.28
• Revenue / Employee: $564,850
• Employees: 394
• Market Cap: 781.56M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	203.07M	39.16M	23.89%
Dec 31, 2023	163.91M	53.67M	48.68%
Dec 31, 2022	110.25M	60.66M	122.32%
Dec 31, 2021	49.59M	29.16M	142.67%
Dec 31, 2020	20.44M	17.71M	650.73%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.